In this Section |
260089 Diversion of Prescription Stimulants by 10 to 18 year olds from N-MAPSSMonday, October 29, 2012
Background: Recent studies on adolescent stimulant abuse discuss reasons for nonmedical use (NMU). Common sources include diversion of medications from friends and relatives with a strong association with the use of illicit substances. Aim: This analysis examines diversion of prescription stimulants (RxStim) among 10-18 year olds from the National Monitoring of Adolescent Prescription Stimulants Study (N-MAPSS). Methods: Youth were recruited for an anonymous survey from entertainment venues in 10 US metropolitan areas. Outgoing diversion (OD) included selling, trading or giving RxStim away. Incoming diversion (ID) included past 30-day use of another's RxStim or ever stealing, borrowing or being given RxStim. Predictive logistic regression models were used. Results: The sample (N=10,889) is 48% male, 43% Caucasian, and 48% urban. Over half (56%) lived with both parents; 13% reported ADD/ADHD. RxStim users (15%) vs. non-users were more likely to be male, older, Caucasian, ADD/ADHD, not live with both parents, fear being overweight, have smoked, drank alcohol, used marijuana, been suspended from school and/or report friend(s) used RxStim (63% vs. 21%). Substance use, school suspension and friend(s) who used RxStim consistently predicted diversion. Older age and fear of overweight predicted ID in both RxStim and non-users. Among RxStim users, not ADD/ADHD also predicted ID but not OD. Among non-users, male gender predicted OD but not ID. Having friend(s) who used RxStim was a stronger predictor in RxStim users than non-users (OR: 3.1-3.7 vs. 1.8-2.0). Conclusions: N-MAPSS findings suggest peer influences play a role in the relationship between RxStim diversion and other drug use.
Learning Areas:
EpidemiologyLearning Objectives: Keywords: Adolescents, Drug Use
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been the principal or co-principal of multiple federally funded grants focusing on the epidemiology of drug abuse, HIV prevention and co-occurring mental and drug use disorders. Among my scientific interests has been the development of strategies for preventing HIV and STDs in out-of-treatment drug users. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3384.0: Addressing Prescription Drug Use & Abuse
|